Please take a moment to review the latest ASCO News
- Administration Outlines Plan to Address High Prescription Drug Costs
- CMS Must Work with Congress to Ensure Adequate Medicare Reimbursement for Cancer Care Services
- Claims to be Reprocessed for 2019 Outpatient Clinic Visit Services at Excepted Off-Campus Provider-Based Departments
- $25.5 Billion Coming from the Provider Relief Fund (Phase 4) and American Rescue Plan; Applications Open September 29
- Oncologists Continue Advocacy Efforts During Congressional Recess
- Questions About Information Blocking? Get Answers on Free September 14 Webinar
- New Certification Pilot Focuses on Patient-Centered Cancer Care, Equips Practices with Evidence-based Approach to Value-based Care Delivery
- Disaster Assistance: Resources Available for Cancer Care Physicians, Patients Impacted by Hurricane Ida
- FDA Approves Zanubrutinib for Waldenström’s Macroglobulinemia
- FDA Approves Ivosidenib for Advanced or Metastatic Cholangiocarcinoma
- FDA Approves Ivosidenib for Advanced or Metastatic Cholangiocarcinoma
- FDA Approves Nivolumab for Adjuvant Treatment of Urothelial Carcinoma
- FDA Approves Nivolumab for Adjuvant Treatment of Urothelial Carcinoma
- Dostarlimab-gxly for dMMR Advanced Solid Tumors Granted Accelerated Approval by the FDA
- New Issue of JCO Oncology Practice Focused on Quality Cancer Care